Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Voriconazole Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Voriconazole Market Overview

    • 1.1 Product Overview and Scope of Voriconazole
    • 1.2 Voriconazole Segment by Type
      • 1.2.1 Global Voriconazole Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Injection
      • 1.2.3 Freeze-dried Powder
    • 1.3 Voriconazole Segment by Application
      • 1.3.1 Voriconazole Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Hospital
      • 1.3.3 Clinic
      • 1.3.4 Other
    • 1.4 Global Voriconazole Market Size Estimates and Forecasts
      • 1.4.1 Global Voriconazole Revenue 2015-2026
      • 1.4.2 Global Voriconazole Sales 2015-2026
      • 1.4.3 Voriconazole Market Size by Region: 2020 Versus 2026

    2 Global Voriconazole Market Competition by Manufacturers

    • 2.1 Global Voriconazole Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Voriconazole Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Voriconazole Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Voriconazole Manufacturing Sites, Area Served, Product Type
    • 2.5 Voriconazole Market Competitive Situation and Trends
      • 2.5.1 Voriconazole Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Voriconazole Players (Opinion Leaders)

    3 Voriconazole Retrospective Market Scenario by Region

    • 3.1 Global Voriconazole Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Voriconazole Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Voriconazole Market Facts & Figures by Country
      • 3.3.1 North America Voriconazole Sales by Country
      • 3.3.2 North America Voriconazole Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Voriconazole Market Facts & Figures by Country
      • 3.4.1 Europe Voriconazole Sales by Country
      • 3.4.2 Europe Voriconazole Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Voriconazole Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Voriconazole Sales by Region
      • 3.5.2 Asia Pacific Voriconazole Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Voriconazole Market Facts & Figures by Country
      • 3.6.1 Latin America Voriconazole Sales by Country
      • 3.6.2 Latin America Voriconazole Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Voriconazole Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Voriconazole Sales by Country
      • 3.7.2 Middle East and Africa Voriconazole Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Voriconazole Historic Market Analysis by Type

    • 4.1 Global Voriconazole Sales Market Share by Type (2015-2020)
    • 4.2 Global Voriconazole Revenue Market Share by Type (2015-2020)
    • 4.3 Global Voriconazole Price Market Share by Type (2015-2020)
    • 4.4 Global Voriconazole Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Voriconazole Historic Market Analysis by Application

    • 5.1 Global Voriconazole Sales Market Share by Application (2015-2020)
    • 5.2 Global Voriconazole Revenue Market Share by Application (2015-2020)
    • 5.3 Global Voriconazole Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Voriconazole Business

    • 6.1 Pfizer
      • 6.1.1 Corporation Information
      • 6.1.2 Pfizer Description, Business Overview and Total Revenue
      • 6.1.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Pfizer Products Offered
      • 6.1.5 Pfizer Recent Development
    • 6.2 Teva
      • 6.2.1 Teva Voriconazole Production Sites and Area Served
      • 6.2.2 Teva Description, Business Overview and Total Revenue
      • 6.2.3 Teva Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Teva Products Offered
      • 6.2.5 Teva Recent Development
    • 6.3 GeneTech Pharm
      • 6.3.1 GeneTech Pharm Voriconazole Production Sites and Area Served
      • 6.3.2 GeneTech Pharm Description, Business Overview and Total Revenue
      • 6.3.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 GeneTech Pharm Products Offered
      • 6.3.5 GeneTech Pharm Recent Development
    • 6.4 Novartis
      • 6.4.1 Novartis Voriconazole Production Sites and Area Served
      • 6.4.2 Novartis Description, Business Overview and Total Revenue
      • 6.4.3 Novartis Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Novartis Products Offered
      • 6.4.5 Novartis Recent Development
    • 6.5 Mylan
      • 6.5.1 Mylan Voriconazole Production Sites and Area Served
      • 6.5.2 Mylan Description, Business Overview and Total Revenue
      • 6.5.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Mylan Products Offered
      • 6.5.5 Mylan Recent Development
    • 6.6 Squibb
      • 6.6.1 Squibb Voriconazole Production Sites and Area Served
      • 6.6.2 Squibb Description, Business Overview and Total Revenue
      • 6.6.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Squibb Products Offered
      • 6.6.5 Squibb Recent Development
    • 6.7 Sandoz
      • 6.6.1 Sandoz Voriconazole Production Sites and Area Served
      • 6.6.2 Sandoz Description, Business Overview and Total Revenue
      • 6.6.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Sandoz Products Offered
      • 6.7.5 Sandoz Recent Development
    • 6.8 Daiichi Sankyo
      • 6.8.1 Daiichi Sankyo Voriconazole Production Sites and Area Served
      • 6.8.2 Daiichi Sankyo Description, Business Overview and Total Revenue
      • 6.8.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Daiichi Sankyo Products Offered
      • 6.8.5 Daiichi Sankyo Recent Development
    • 6.9 GSK
      • 6.9.1 GSK Voriconazole Production Sites and Area Served
      • 6.9.2 GSK Description, Business Overview and Total Revenue
      • 6.9.3 GSK Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 GSK Products Offered
      • 6.9.5 GSK Recent Development
    • 6.10 Cilag AG
      • 6.10.1 Cilag AG Voriconazole Production Sites and Area Served
      • 6.10.2 Cilag AG Description, Business Overview and Total Revenue
      • 6.10.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Cilag AG Products Offered
      • 6.10.5 Cilag AG Recent Development
    • 6.11 Macherey-Nagel GmbH
      • 6.11.1 Macherey-Nagel GmbH Voriconazole Production Sites and Area Served
      • 6.11.2 Macherey-Nagel GmbH Voriconazole Description, Business Overview and Total Revenue
      • 6.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Macherey-Nagel GmbH Products Offered
      • 6.11.5 Macherey-Nagel GmbH Recent Development
    • 6.12 Abbott
      • 6.12.1 Abbott Voriconazole Production Sites and Area Served
      • 6.12.2 Abbott Voriconazole Description, Business Overview and Total Revenue
      • 6.12.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Abbott Products Offered
      • 6.12.5 Abbott Recent Development
    • 6.13 Takeda
      • 6.13.1 Takeda Voriconazole Production Sites and Area Served
      • 6.13.2 Takeda Voriconazole Description, Business Overview and Total Revenue
      • 6.13.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 Takeda Products Offered
      • 6.13.5 Takeda Recent Development
    • 6.14 Sichuan Beauty Sport Huakang Pharmaceutical
      • 6.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Production Sites and Area Served
      • 6.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Description, Business Overview and Total Revenue
      • 6.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Products Offered
      • 6.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
    • 6.15 Jincheng HEALTH Pharmaceutical
      • 6.15.1 Jincheng HEALTH Pharmaceutical Voriconazole Production Sites and Area Served
      • 6.15.2 Jincheng HEALTH Pharmaceutical Voriconazole Description, Business Overview and Total Revenue
      • 6.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.15.4 Jincheng HEALTH Pharmaceutical Products Offered
      • 6.15.5 Jincheng HEALTH Pharmaceutical Recent Development
    • 6.16 Ebang Pharmaceutical
      • 6.16.1 Ebang Pharmaceutical Voriconazole Production Sites and Area Served
      • 6.16.2 Ebang Pharmaceutical Voriconazole Description, Business Overview and Total Revenue
      • 6.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.16.4 Ebang Pharmaceutical Products Offered
      • 6.16.5 Ebang Pharmaceutical Recent Development
    • 6.17 Aditya Pharma
      • 6.17.1 Aditya Pharma Voriconazole Production Sites and Area Served
      • 6.17.2 Aditya Pharma Voriconazole Description, Business Overview and Total Revenue
      • 6.17.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.17.4 Aditya Pharma Products Offered
      • 6.17.5 Aditya Pharma Recent Development
    • 6.18 Taj Pharmaceuticals
      • 6.18.1 Taj Pharmaceuticals Voriconazole Production Sites and Area Served
      • 6.18.2 Taj Pharmaceuticals Voriconazole Description, Business Overview and Total Revenue
      • 6.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2015-2020)
      • 6.18.4 Taj Pharmaceuticals Products Offered
      • 6.18.5 Taj Pharmaceuticals Recent Development

    7 Voriconazole Manufacturing Cost Analysis

    • 7.1 Voriconazole Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Voriconazole
    • 7.4 Voriconazole Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Voriconazole Distributors List
    • 8.3 Voriconazole Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Voriconazole Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Voriconazole by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Voriconazole by Type (2021-2026)
    • 10.2 Voriconazole Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Voriconazole by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Voriconazole by Application (2021-2026)
    • 10.3 Voriconazole Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Voriconazole by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Voriconazole by Region (2021-2026)
    • 10.4 North America Voriconazole Estimates and Projections (2021-2026)
    • 10.5 Europe Voriconazole Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Voriconazole Estimates and Projections (2021-2026)
    • 10.7 Latin America Voriconazole Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Voriconazole Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global Voriconazole market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
      This report focuses on Voriconazole volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Voriconazole market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the Voriconazole market is segmented into
      Injection
      Freeze-dried Powder

      Segment by Application
      Hospital
      Clinic
      Other

      Global Voriconazole Market: Regional Analysis
      The Voriconazole market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Voriconazole market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global Voriconazole Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global Voriconazole market include:
      Pfizer
      Teva
      GeneTech Pharm
      Novartis
      Mylan
      Squibb
      Sandoz
      Daiichi Sankyo
      GSK
      Cilag AG
      Macherey-Nagel GmbH
      Abbott
      Takeda
      Sichuan Beauty Sport Huakang Pharmaceutical
      Jincheng HEALTH Pharmaceutical
      Ebang Pharmaceutical
      Aditya Pharma
      Taj Pharmaceuticals

      Buy now